Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Associated Fatty Liver Disease-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes in Real World

NCT04761900 is registered in ClinicalTrials.gov with Ningbo No. 1 Hospital as lead sponsor.

NCT NCT04761900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04761900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Associated Fatty Liver Disease-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes in Real World
Lead sponsor
Ningbo No. 1 Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 31, 2020
Enrollment
3,372 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic associated fatty liver disease